600518.SS · 康美药业
China A-shares · RS rating 36 · As of 2026-10-14
| Price | 1.33 CNY |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 60 / 66 / 18 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 20 / 13 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -16.5% |
| Distance from 52-week high | +37.6% |
| Market cap (USD) | $2.8B |